• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4678229)   Today's Articles (454)
For: Panaccione R. The Great Debate With IBD Biosimilars: Con: Biosimilars Should Not Be Routinely Used as a First Line Biologic and Not Switched From Reference Biologics. Crohns Colitis 360 2021;3:otab038. [PMID: 36776671 PMCID: PMC9802193 DOI: 10.1093/crocol/otab038] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Indexed: 12/25/2022]  Open
Number Cited by Other Article(s)
1
Maltz RM, McNicol M, Wingate L, Buchanan S, Sandell A, Kim SC, Rubin DT. There Is No Substitute for Effective Education About Biosimilars. CROHN'S & COLITIS 360 2021;3:otab047. [PMID: 36777278 PMCID: PMC9802262 DOI: 10.1093/crocol/otab047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA